Seeking Alpha

Aurelius to buy Scholl from Reckitt Benckiser

  • German private equity firm Aurelius has agreed to buy Reckitt Benckiser's (OTCPK:RBGLY) Scholl shoe business. The company is expecting the brand to expand internationally and maintain growth.
  • Aurelius will acquire the international rights to the business, except for North and South America, which will go to Bayer (OTCPK:BAYRY) as part of its $14B purchase of Merck (NYSE:MRK).
  • The deal is expected to close in the third quarter of 2014.
Comments (1)
  • biochemist
    , contributor
    Comments (389) | Send Message
    That should read "as part of its $14B purchase of Merck's consumer business".
    21 Jul, 02:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector